Joinn Laboratories (China) Co (SHSE:603127) Other Operating Expense : ¥174 Mil (TTM As of Mar. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Joinn Laboratories (China) Co Other Operating Expense?

Joinn Laboratories (China) Co's Other Operating Expense for the three months ended in Mar. 2024 was ¥-4 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2024 was ¥174 Mil.

Joinn Laboratories (China) Co's quarterly Other Operating Expense increased from Sep. 2023 (¥-112 Mil) to Dec. 2023 (¥183 Mil) but then declined from Dec. 2023 (¥183 Mil) to Mar. 2024 (¥-4 Mil).

Joinn Laboratories (China) Co's annual Other Operating Expense increased from Dec. 2021 (¥127 Mil) to Dec. 2022 (¥195 Mil) but then declined from Dec. 2022 (¥195 Mil) to Dec. 2023 (¥169 Mil).

Joinn Laboratories (China) Co Other Operating Expense Historical Data

The historical data trend for Joinn Laboratories (China) Co's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Joinn Laboratories (China) Co Other Operating Expense Chart

Joinn Laboratories (China) Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Operating Expense

Get a 7-Day Free Trial

38.55

102.81

126.92

194.72

168.67

Joinn Laboratories (China) Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Operating Expense	Get a 7-Day Free Trial															-9.68	107.31	-111.77	182.81	-4.28

Joinn Laboratories (China) Co Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥174 Mil.

Joinn Laboratories (China) Co Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Joinn Laboratories (China) Co's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Joinn Laboratories (China) Co (SHSE:603127) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Joinn Laboratories (China) Co Ltd (SHSE:603127) » Definitions » Other Operating Expense

Comparable Companies

Traded in Other Exchanges

06127:Hong Kong

Address

A5 Rongjing East Street, Beijing Economic-Technological Development Area, Beijing, CHN, 100176

Website

https://www.joinnlabs.com

Joinn Laboratories (China) Co Ltd is a non-clinical contract research organization(CRO) focused on drug safety assessment. It operates in three segments: Non-clinical studies services include drug safety assessment, drug metabolism & pharmacokinetics (DMPK) studies, & pharmacology & efficacy studies; Clinical trial & related services segment provides early-stage services such as clinical CRO services, co-managed phase I clinical research units, & bioanalytical services, and: Sales of research models engages in the design, production, breeding, & sales of research models, currently including non-human primates and rodents. The majority is from the Non- Clinical studies services. Its geographical segments are China, the United States, and Other countries, of which the majority is from China.

Executives

Yao Da Lin	Director
Sun Yun Xia	Director
Zuo Cong Lin	Director
Gao Da Peng	Director
Li Ye	Supervisors
Gu Xiao Lei	Director
Feng Yu Xia	Director
Gu Jing Liang	senior management
Yu Ai Shui	senior management
Yin Li Li	Supervisors
Sun Hui Ye	Supervisors
Gu Mei Fang	Director

Joinn Laboratories (China) Co (SHSE:603127) Headlines

No Headlines